Filtered By:
Infectious Disease: Meningitis
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 68 results found since Jan 2013.
Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):912-919. doi: 10.15585/mmwr.mm7234a3.ABSTRACTThree vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). CDC analyzed data from the 2022 National Immunization Survey-Teen for 16,043 adolescents aged 13-17 years to assess vaccination coverage. Birth cohort analyses were conducted to assess trends in vaccination coverage by age 13 years (i.e., before the 13th birthday) and by age 14 years (i.e., before the 14th birthday) among adolescents who were due for routine vaccination before and dur...
Source: MMWR Morb Mortal Wkl... - August 24, 2023 Category: Epidemiology Authors: Cassandra Pingali David Yankey Laurie D Elam-Evans Lauri E Markowitz Madeleine R Valier Benjamin Fredua Samuel J Crowe Carla L DeSisto Shannon Stokley James A Singleton Source Type: research
Human papillomavirus vaccination at the first opportunity: An overview
Hum Vaccin Immunother. 2023 May 23:2213603. doi: 10.1080/21645515.2023.2213603. Online ahead of print.ABSTRACTThe Advisory Committee on Immunization Practices (ACIP) has recommended human papillomavirus (HPV) vaccination for adolescents in the United States since 2006. Though recommended at a similar time to the routine recommendations for adolescent tetanus, diphtheria, and acellular pertussis vaccination (Tdap) and quadrivalent meningococcal vaccination (MCV4), HPV vaccine uptake has consistently lagged behind these other adolescent vaccines. The ACIP recommends HPV vaccination at 11-12 y, with vaccination starting at 9 ...
Source: Cancer Control - May 23, 2023 Category: Cancer & Oncology Authors: Robert A Bednarczyk Noel T Brewer Melissa B Gilkey Sherri Zorn Rebecca B Perkins Kristin Oliver Debbie Saslow Source Type: research
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states
CONCLUSIONS: Adolescent HPV vaccination coverage remains low in our targeted states. Children's age, sex, and parental vaccine hesitancy were significantly associated with likelihood of HPV vaccination. These findings offer the opportunity for targeted interventions among parents in regions with low vaccine uptake and underscore the importance of developing and implementing strategies to address parental HPV vaccination hesitancy to improve uptake in the US.PMID:37198022 | DOI:10.1016/j.vaccine.2023.04.082
Source: Vaccine - May 17, 2023 Category: Allergy & Immunology Authors: T Shato S Humble A Anandarajah A Barnette H M Brandt J Garbutt L Klesges V S Thompson M I Silver Source Type: research
Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen
Hum Vaccin Immunother. 2023 Dec 31;19(1):2204784. doi: 10.1080/21645515.2023.2204784.ABSTRACTHuman papillomavirus (HPV) vaccination uptake in the United States remains suboptimal, and continues to trail that of tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and quadrivalent meningococcal conjugate vaccination (MCV4). This is despite these three vaccines all being recommended for routine adolescent use within the 2005-2006 time period. One strategy to improve HPV vaccination is starting the vaccine series at the first opportunity - currently as young as 9 years of age. Little is known about the epidemiology...
Source: Cancer Control - May 4, 2023 Category: Cancer & Oncology Authors: Robert A Bednarczyk Heather M Brandt Source Type: research
Vaccine co-administration in adults: An effective way to improve vaccination coverage
Hum Vaccin Immunother. 2023 Apr 11:2195786. doi: 10.1080/21645515.2023.2195786. Online ahead of print.ABSTRACTThe ongoing COVID-19 pandemic highlights that complications and mortality associated with infectious diseases increase with age. Various vaccines are recommended for adults, but coverage rates remain suboptimal. Although co-administration would improve vaccine uptake and timely immunization, this is not routine practice in adults. We review key data on co-administration of vaccines in children and adults to reassure healthcare providers about its safety and advantages. In European countries and the United States, c...
Source: Herpes - April 11, 2023 Category: Infectious Diseases Authors: Paolo Bonanni Robert Steffen J örg Schelling Lina Balaisyte-Jazone Inga Posiuniene Maciej Zato ński Pierre Van Damme Source Type: research
Latino Adolescent-Mother Language Concordance, Neighborhood Deprivation, and Vaccinations in Community Health Centers
Conclusions: In a multistate analysis of vaccinations among Latino and non-Latino adolescents, English-preferring adolescents with Spanish- preferring mothers had the highest completion rates and English-preferring non-Hispanic white dyads had the lowest. Further research can seek to understand why this language dyad may have an advantage in adolescent vaccination completion.PMID:36976843 | DOI:10.1370/afm.21.s1.3815
Source: Annals of Family Medicine - March 28, 2023 Category: Primary Care Authors: Rachel Springer John Heintzman Jorge Kaufmann Sophia Giebultowicz Miguel Marino Nathaniel Warren Heather Angier Source Type: research
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
DiscussionAlthough (mild) AEFI were demonstrated for all five studied vaccines, only a quarter of reviewed studies accounted for these, mostly in an incomplete and inaccurate manner. We provide guidance on which methods to use to better quantify the impact of AEFI on both costs and health outcomes. Policymakers should be aware that the impact of AEFI on cost-effectiveness is likely to be underestimated in the majority of economic evaluations.
Source: PharmacoEconomics - February 21, 2023 Category: Health Management Source Type: research
Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS)
CONCLUSIONS: POI is rarely reported to VAERS. Most reports contained limited diagnostic information and were submitted after published cases of POI following HPV vaccination. Results of our review do not suggest a safety concern.PMID:36732165 | DOI:10.1016/j.vaccine.2022.12.038
Source: Vaccine - February 2, 2023 Category: Allergy & Immunology Authors: A Patricia Wodi Paige Marquez Adamma Mba-Jonas Faith Barash Kosal Nguon Pedro L Moro Source Type: research
